checkAd
    Startseite > Aktien > Champions Oncology > Nachrichten
    Champions Oncology Aktie
    4,6800
     
    USD
    -0,64 %
    -0,0300 USD
    Letzter Kurs 22:30:00 NMS
    4,5900
     
    USD
    100 STK
    Geldkurs 22:02:00
    4,7600
     
    USD
    200 STK
    Briefkurs 22:02:00
    ISIN: US15870P3073 · WKN: A14X6S · SYM: CSBR · USA

    Neueste Nachrichten

    Champions Oncology Reports Quarterly Revenue of $12.0 Million
    12.03.24 · Accesswire · Champions Oncology
    Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
    07.03.24 · Accesswire · Champions Oncology
    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
    06.03.24 · Accesswire · Champions Oncology
    Champions Oncology Reports Quarterly Revenue of $11.6 Million
    12.12.23 · Accesswire · Champions Oncology
    Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
    04.12.23 · Accesswire · Champions Oncology
    Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001: 2015-Akkreditierung und ATS-Zertifizierung
    02.11.23 · IRW Press · Champions Oncology
    Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
    02.11.23 · Accesswire · Champions Oncology
    Champions Oncology Announces the Addition of Brady Davis as President
    17.10.23 · Accesswire · Champions Oncology
    Champions Oncology Reports Quarterly Revenue of $12.6 Million
    13.09.23 · Accesswire · Champions Oncology
    Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
    11.09.23 · Accesswire · Champions Oncology
    Champions Oncology Announces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
    22.08.23 · Accesswire · Champions Oncology
    Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
    01.08.23 · Accesswire · Champions Oncology